BD BBL™ Rapid Urea Broth 298330Recalls & reported problems
Becton, Dickinson And Company · BD BBL™ Rapid Urea Broth, Package of 10 vials · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 30382902983300), received between Oct 21, 2021 and Oct 21, 2021 — classified as 2 malfunctions.
The most frequently reported specific device problem is “False Positive Result” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- False Positive Result2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 21, 2021False Positive Result; False Positive Result
IT WAS REPORTED THAT WHILE USING BD BBL¿ RAPID UREA BROTH FALSE POSITIVE RESULTS WERE OBTAINED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER REPORTS INCREASED POSITIVITY THAT IS DISCREPANT WITH PATHOLOGY BIOPSY RESULTS WITH USE OF MEDIA ITEM 298330-BBL RAPID UREA BROTH. ".
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12677558 ↗MalfunctionOct 21, 2021False Positive Result; False Positive Result
IT WAS REPORTED THAT WHILE USING BD BBL¿ RAPID UREA BROTH FALSE POSITIVE RESULTS WERE OBTAINED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER REPORTS INCREASED POSITIVITY THAT IS DISCREPANT WITH PATHOLOGY BIOPSY RESULTS WITH USE OF MEDIA ITEM 298330-BBL RAPID UREA BROTH. "
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12677548 ↗
Other CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL devices
- BBL™ CHROMagar™ Orientation 215081Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL73 reports
- REMEL R01202Remel, Inc. · Culture Media, Non-Selective And Differential1 recall0 reports
- BD BBL™ CHROMAgar™ Orient/TSA II W/5% SB 222239Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL41 reports
- BD BBL™ Kligler Iron Agar Slants 220897Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL5 reports
- BD BBL™ CHROMagar™ Orientation Agar 254102Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL2 reports
- BD BBL™ Urease Test Broth 221719Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL1 report
- BD BBL™ Simmons Citrate Agar Slants 221026Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page